| Literature DB >> 30120420 |
Ryan Sun1, Zhaoxi Wang2, Birgit Claus Henn3, Li Su2, Quan Lu2, Xihong Lin4, Robert O Wright5, David C Bellinger6, Molly Kile7, Maitreyi Mazumdar8, Martha Maria Tellez-Rojo9, Lourdes Schnaas9, David C Christiani2.
Abstract
It is believed that genetic factors play a large role in the development of many cognitive and neurological processes; however, epidemiological evidence for the genetic basis of childhood neurodevelopment is very limited. Identification of the genetic polymorphisms associated with early-stage neurodevelopment will help elucidate biological mechanisms involved in neuro-behavior and provide a better understanding of the developing brain. To search for such variants, we performed a genome-wide association study (GWAS) for infant mental and motor ability at two years of age with mothers and children recruited from cohorts in Bangladesh and Mexico. Infant ability was assessed using mental and motor composite scores calculated with country-specific versions of the Bayley Scales of Infant Development. A missense variant (rs1055153) located in the gene WWTR1 reached genome-wide significance in association with mental composite score (meta-analysis effect size of minor allele βmeta = -6.04; 95% CI: -8.13 to -3.94; P = 1.56×10-8). Infants carrying the minor allele reported substantially lower cognitive scores in both cohorts, and this variant is predicted to be in the top 0.3% of most deleterious substitutions in the human genome. Fine mapping and region-based association testing provided additional suggestive evidence that both WWTR1 and a second gene, LRP1B, were associated with infant cognitive ability. Comparisons with recently conducted GWAS in intelligence and educational attainment indicate that our phenotypes do not possess a high genetic correlation with either adolescent or adult cognitive traits, suggesting that infant neurological assessments should be treated as an independent outcome of interest. Additional functional studies and replication efforts in other cohorts may help uncover new biological pathways and genetic architectures that are crucial to the developing brain.Entities:
Mesh:
Year: 2018 PMID: 30120420 PMCID: PMC6378130 DOI: 10.1038/s41380-018-0205-3
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 15.992
Demographic, clinical, and neurological assessment data for Bangladesh and Mexico cohorts
| Characteristics | Mean (SD) or n (%) | |
|---|---|---|
| Bangladesh (n=502) | Mexico (n=462) | |
| Male | 256 (51) | 245 (53) |
| Female | 246 (49) | 217 (47) |
| Manganese | 5.92 (4.45) | 3.20 (1.11) |
| Lead | 4.72 (4.04) | 3.83 (2.70) |
| Gestational Age, weeks | 38.2 (1.7) | 38.4 (1.6) |
| Age at Exam, weeks | 99.4 (18.5) | 106.1 (2.4) |
| Mother’s Education > Primary, No. (%) | 269 (54) | 269 (58) |
| Smoking in Household Environment, No. (%) | 212 (42) | 172 (37) |
| Mental Composite | 112.7 (10.5) | 108.5 (9.7) |
| Motor Composite | 92.7 (5.0) | 91.8 (4.6) |
Abbreviations: SD, standard deviation; CI, confidence interval.
There were 23 subjects in the Bangladesh cohort and 73 in the Mexico cohort who did not have any recorded values for metal concentration. Also, for each of the metals separately, we classified subjects with a measured value greater than 5 standard deviations from the median as outliers and removed them from analysis with that metal due to possible measurement error. This procedure resulted in the removal of 3 subjects from the manganese sample and 2 subjects from the lead sample, all from the Bangladesh cohort.
Two top SNPs from initial GWAS meta-analysis and their association with infant mental and motor composite score
| Mental Composite Score | Motor Composite Score | ||||||
|---|---|---|---|---|---|---|---|
| Cohort | Effect Size | 95% CI | Effect Size | 95% CI | MAF | ||
| Meta-Analysis | −6.04 (1.07) | −8.13 to −3.94 | 1.56×10−8 | −2.21 (0.52) | −3.22 to −1.19 | 2.17× 10−5 | 0.05 |
| Bangladesh | −5.56 (1.24) | −7.98 to −3.14 | 8.68× 10−6 | −2.26 (0.60) | −3.43 to −1.09 | 1.68× 10−4 | 0.08 |
| Mexico | −7.43 (2.11) | −11.58 to −3.29 | 4.84× 10−4 | −2.04 (1.06) | −4.11 to 0.04 | 5.54× 10−2 | 0.02 |
| Meta-Analysis | 2.01 (0.47) | 1.09 to 2.93 | 1.86× 10−5 | 0.95 (0.23) | 0.50 to 1.40 | 3.63× 10−5 | 0.33 |
| Bangladesh | 1.54 (0.74) | 0.09 to 2.98 | 3.72× 10−2 | 0.74 (0.35) | 0.05 to 1.44 | 3.52× 10−2 | 0.27 |
| Mexico | 2.34 (0.61) | 1.14 to 3.53 | 1.47× 10−4 | 1.10 (0.30) | 0.51 to 1.69 | 3.15× 10−4 | 0.40 |
Abbreviations: SD, standard error; CI, confidence interval; MAF, minor allele frequency
Effect size refers to the estimated mean change in outcome for one additional minor allele, holding all other covariates constant.
SNP position recorded from NCBI Build 37/UCSC hg19 coordinates. This SNP resides in the gene WWTR1, and the minor allele is T.
SNP position recorded from NCBI Build 37/UCSC hg19 coordinates. This SNP resides in the gene LRP1B, and the minor allele is A.
Figure 1Population mental and motor composite score by number of minor alleles at rs1055153
Boxplots for mental composite score (Panel A) and motor composite score (Panel B) within Bangladesh and Mexico. No subject in the entire study had two copies of the minor allele at this SNP. Thick black line shows the median, and the box ends at the first and third quartiles. Whiskers extend to 1.5 times the interquartile range.
Figure 2Local Manhattan plot for association with mental composite score and motor composite score in WWTR1 and LRP1B
Meta-analysis P-values for both originally genotyped SNPs and imputed SNPs at WWTR1 (Panel A) and LRP1B (Panel B). Asterisk (*) used to denote the top SNPs from the initial analysis (rs1055153 in WWTR1 and rs13013197 in LRP1B). Solid icons denote SNPs that have squared Pearson correlation coefficient r2 greater than or equal to 0.5 with the top SNPs in both cohorts. SNPs with meta-analysis P-values less than 0.01 are shown in grey to demonstrate contrast in gene-wide association levels between WWTR1 and LRP1B.
Association of SNP-metal interaction with infant mental and motor composite score for top two SNPs
| Model | Effect Size | 95% CI | |
|---|---|---|---|
| Mental Composite Score | 0.24 (0.36) | −0.47 to 0.95 | 5.07× 10−1 |
| Motor Composite Score | 0.15 (0.16) | −0.17 to 0.46 | 1.67× 10−1 |
| Mental Composite Score | −0.65 (0.26) | −1.16 to −0.14 | 1.30× 10−2 |
| Motor Composite Score | −0.27 (0.08) | −0.43 to −0.10 | 1.69× 10−3 |
| Mental Composite Score | −0.07 (0.10) | −0.28 to 0.13 | 4.77× 10−1 |
| Motor Composite Score | 0.01 (0.06) | −0.12 to 0.13 | 9.11× 10−1 |
| Mental Composite Score | −0.12 (0.19) | −0.50 to 0.25 | 5.15× 10−1 |
| Motor Composite Score | −0.02 (0.07) | −0.15 to 0.11 | 7.53× 10−1 |
Abbreviations: CI, confidence interval; SD, standard deviation.
Effect size refers to the estimated additional change in Bayley score for each unit increase in concentration (ug/dl) of metal exposure in umbilical cord blood, while holding all other covariates constant, for each additional minor allele.